Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
A

Acarix AB
STO:ACARIX

Watchlist Manager
Acarix AB
STO:ACARIX
Watchlist
Price: 0.2395 SEK 0.21%
Market Cap: kr269m
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one ACARIX stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.2395 SEK, Acarix AB is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACARIX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

ACARIX Competitors Multiples
Acarix AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Acarix AB
STO:ACARIX
269m SEK 39.6 -5.2 -5 -4.7
US
Abbott Laboratories
NYSE:ABT
186.1B USD 4.2 28.8 16.4 22.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
178B USD 17.4 61.4 46.8 56.7
US
Stryker Corp
NYSE:SYK
141.5B USD 5.6 43 21.8 26.4
US
Boston Scientific Corp
NYSE:BSX
137.7B USD 7 48.8 28.6 38.9
IE
Medtronic PLC
NYSE:MDT
133B USD 3.8 28 15.6 22.6
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD 2.7 35.2 12.9 21.9
DE
Siemens Healthineers AG
XETRA:SHL
47.1B EUR 2 22.2 12.5 17.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.2B USD 12.1 49.2 35.4 39.2
US
Edwards Lifesciences Corp
NYSE:EW
48B USD 8.2 35.1 25 27.4
US
Resmed Inc
NYSE:RMD
37.3B USD 6.9 25 17.7 19.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
A
Acarix AB
STO:ACARIX
Average EV/EBITDA: 23.3
Negative Multiple: -5 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.4
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
46.8
24%
2
US
Stryker Corp
NYSE:SYK
21.8
12%
1.8
US
Boston Scientific Corp
NYSE:BSX
28.6
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.6
8%
2
US
Becton Dickinson and Co
NYSE:BDX
12.9
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.5
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.4
14%
2.5
US
Edwards Lifesciences Corp
NYSE:EW
25
13%
1.9
US
Resmed Inc
NYSE:RMD
17.7
11%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
A
Acarix AB
STO:ACARIX
Average EV/EBIT: 29.3
Negative Multiple: -4.7 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.3
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
56.7
25%
2.3
US
Stryker Corp
NYSE:SYK
26.4
16%
1.6
US
Boston Scientific Corp
NYSE:BSX
38.9
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.6
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.7
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.2
15%
2.6
US
Edwards Lifesciences Corp
NYSE:EW
27.4
14%
2
US
Resmed Inc
NYSE:RMD
19.6
12%
1.6

See Also

Summary
ACARIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACARIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACARIX stock valuation using valuation multiples.
Wall Street Estimates
ACARIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACARIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.